Continuing Challenges in Treating Most Aggressive CLL

patientpower has 2377 videos Subscribe Here

Description: While there is a lot of excitement about new agents for CLL and how they might help patients who have more aggressive disease, the latest research is showing the drugs are not a perfect match for a subset of the sickest patients, those who have the 17p genetic deletion in their cancer cells. Professor Peter Hillmen from Leeds University in the United Kingdom explains what researchers are learning about the challenges of fighting cancer in patients with 17p.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 11/15/13
Added : 4 years ago
Category : General